Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lovenox

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lovenox was produced by Sanofi.

HIV prevention pill heads July CHMP recommendations

HIV prevention pill heads July CHMP recommendations

Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -

Heart drug sales continue downward spiral

Heart drug sales continue downward spiral Sanofi has a number of CV medicines including Aprovel (irbesartan), Lovenox (enoxaparin) and the co-marketed Plavix (clopidogrel), which collectively made the firm 4.2bn euro ($4.7bn) last year, helping

European licence for BMS/Pfizer's Eliquis in DVT and PE

European licence for BMS/Pfizer's Eliquis in DVT and PE safety endpoint of major bleeding versus warfarin and enoxaparin - the active ingredient in Sanofi's out-of-patent anticoagulant Lovenox.  .

Sanofi returns to growth in Q3

Sanofi returns to growth in Q3 Lovenox (enoxaparin) and Aprovel/Avapro (irbesartan) for high blood pressure continued to slide.

Sanofi cuts forecasts but says worst effects of patent cliff have passed

Sanofi cuts forecasts but says worst effects of patent cliff have passed drugs such as blood thinners Lovenox (enoxaparin) and Plavix (clopidogrel) recedes and growth platforms - including diabetes, vaccines and speciality medicine subsidiary Genzyme - gain the ascendancy.

1 2 3 4 5 6 7 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics